Turning an uncertain diagnosis into an empowered plan

Meet Kenna, a cancer survivor, wife, and mother of six. After hitting her head at work, she noticed an arc of light in her vision and assumed a minor retinal issue — until her doctor told her she had a tumor. Later that day, an email confirming her follow-up appointment carried an unfamiliar phrase: choroidal melanoma. After meeting with her ocular oncologist in Tucson, Kenna chose to move forward with Castle Biosciences’ DecisionDx-UM testing to better understand her risk of metastasis. Her result came back Class 2, PRAME negative — an intermediate-risk finding that was, at first, frustrating to sit with. But knowing where she stood ultimately gave Kenna a clear plan for how often to be scanned and when to see a medical oncologist, replacing uncertainty with a sense of control over her own care.